Dystonia Drugs Market Share

On the basis of geographical analysis, the dystonia drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in the Asia Pacific is expected to dominate majority revenue share by 2036, on the back of increase in the geriatric population, large patient pool, and rapid growth of pharmaceutical sector in countries such as China, Japan and India. As per another report by the WHO, the total percentage of people aged 60 or above was 9.8 percent in 2017, which is evaluated to increase up to 13.7 percent and 20.3 percent by the end of 2030 and 2050.  Additionally, the market in North America is projected to grab the largest share during the forecast period, which can be ascribed to the rising private and venture funding in the healthcare sector in the United States, and growing improvements in reimbursement policies. Along with these, strong presence of prominent medical companies is also anticipated to boost the growth of the region’s dystonia drugs market in the coming years.